Rottapharm stays quiet over stake sale rumours
This article was originally published in Scrip
Executive Summary
Rottapharm has nothing to say about press rumours that its founding Rovati family is about to sell a 50% stake in the firm to private equity firms. A spokesperson for the Italian firm told Scrip that it had met funds in autumn 2011 "but nothing concrete had come of it" and the matter was closed.